Coronavirus disease-2019 (COVID-19): value of IL-6 inhibitors

E. L. Nasonov

PULMONOLOGIYA
Russian Pulmonology Journal

ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)

User

eng | рус

PULMONOLOGIYA

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Nasonov E.L. Coronavirus disease-2019 (COVID-19): value of IL-6 inhibitors. PULMONOLOGIYA. 2020;30(5):629-644. https://doi.org/10.18093/0869-0189-2020-30-5-629-644

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Aleksandr G. Chuchalin

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Author

E. L. Nasonov
V.A.Nasonova Federal Research Rheumatology Institute; I.M.Sechenov First Moscow State Medical University (Sechenov University), Healthcare Ministry of Russia
Russian Federation

Evgeny L. Nasonov – Doctor of Medicine, Professor, Academician of Russian Academy of Sciences, President of the Association of Rheumatologists of Russia; Scientific Director, V.A.Nasonova Federal Research Rheumatology Institute; Chief Specialist-Rheumatologist of Healthcare Ministry of Russia; Professor of the Department of Internal, Occupational Diseases and Rheumatology, I.M.Sechenov First Moscow State Medical University (Sechenov University), Healthcare Ministry of Russia; Chief Editor of the Journal “Scientific and Practical Rheumatology”

Kashirskoe shosse 34A, Moscow, 115522
ul. Trubetskaya 8, build. 2, Moscow, 119991
tel.: (495) 109-29-11

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

PULMONOLOGIYA

For citations:

Cookies policy